Redaktionelle Informationen

Trinseo Continues its Focus on Drug Delivery Devices with Rigid and Soft Plastics

Company will Showcase Resins at Medtec Europe in Stuttgart, April 17 - 19

BERWYN, Pa. - Tuesday, April 17, 2018

Last year, Trinseo (NYSE: TSE), a global materials solutions provider and manufacturer of plastics, latex binders and synthetic rubber, began supporting the Drug Delivery Devices market with its specialty engineered resins. The company has highlighted its materials at trade shows worldwide including MD&M West in California, Pharmapack in Paris, and the International Component Manufacturing and Design Show in Shanghai.

Trinseo will be showcasing its plastic resins at Medtec Europe in Stuttgart from April 17 to 19, co-located with one of its European distributor partners VELOX in Hall 9, Booth 9E38. 

Typical drug delivery devices, also known as pre-filled or combination devices that can use Trinseo materials include auto injectors, insulin pens, asthma inhalers, prefilled syringes and wearable devices. The company’s specialty compounded solutions are ideal for a wide range of applications – MAGNUM™ ABS, CALIBRE™ Polycarbonate, STYRON Polystyrene, and EMERGE™ Advanced Resins for rigid plastic applications, and RAPLAN™ and MEGOL™ Thermoplastic Elastomers for soft touch and over molding needs.

Trinseo is ISO 13485 certified and a trusted partner of global product designers, manufacturers and molders of medical devices. Large and global in its infrastructure yet agile in its service model, the company is known for its quality, technical knowledge, and regulatory support services, which enable customers to lower risk and take products to market sooner.  

As the healthcare industry continues to look for ways to enhance patient care, improve quality of life, and reduce costs, self-administered therapies are providing a viable solution. Health care providers need devices that are effective therapeutically and also are convenient, functional and aesthetically pleasing.  Plastic resin materials are a big part of the solution. Trinseo, with nearly three decades of experience with medical polymers, is supporting global customers with this challenge.

Contact Wassim Berrak to arrange a time to meet at the show or connect with Trinseo at www.trinseo.com.

About Trinseo

Trinseo (NYSE:TSE) is a global materials solutions provider and manufacturer of plastics, latex binders, and synthetic rubber with a focus on delivering innovative, sustainable, and value-creating products that are intrinsic to our daily lives. Trinseo is dedicated to making a positive impact on society by partnering with like-minded stakeholders, and supporting the sustainability goals of our customers in a wide range of end-markets including automotive, consumer electronics, appliances, medical devices, packaging, footwear, carpet, paper and board, building and construction, and tires. Trinseo had approximately $3.8 billion in net sales with 2,700 employees globally in 2019. For more information, please visit: www.trinseo.com.

Note on Forward-Looking Statements

This press release may contain “forward-looking statements” including, without limitation, statements concerning plans, objectives, goals, projections, expectations, strategies, future events or performance, and underlying assumptions and other statements, which are not statements of historical facts. Forward-looking statements may be identified by the use of words like “expect,” “estimate,” “will,” “may,” or expressions of similar meaning. Forward-looking statements reflect management’s evaluation of information currently available and are based on the Company’s current expectations and assumptions regarding the impact from the COVID-19 pandemic, the Company’s business, the economy and other future conditions. Specific factors that could cause future results to differ from those expressed by the forward-looking statements include, but are not limited to, risks related to the ongoing impact of the COVID-19 pandemic and those discussed in the Company’s Annual Report for the year ended December 31, 2019 filed with the Securities and Exchange Commission (“SEC”), in subsequent Quarterly Reports on Form 10-Q and in other filings and furnishings made by the Company with the SEC from time to time. Other unknown or unpredictable factors could also have material adverse effects on the Company’s performance. As a result of these or other factors, the Company’s actual results may differ materially from those contemplated by the forward-looking statements. The forward-looking statements included in this press release are made only as of the date hereof and are not a guarantee of future performance. The Company undertakes no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.

Redaktionelle Informationen

Exklusive Trinseo-Inhalte erhalten

Seien Sie der Erste, der über neue Produktinformationen, Unternehmensnachrichten und weitere Trinseo-Updates bequem per E-Mail informiert wird!